No Data
No Data
Express News | GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board
10-Q: Q2 2024 Earnings Report
Express News | GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
Express News | Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review
Express News | GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review
Express News | GeoVax to Report Second Quarter 2024 Financial Results and Provide Corporate Update on August 6, 2024
No Data